New approaches to assessing the risks of hyperbilirubinemia
- PMID: 2196132
New approaches to assessing the risks of hyperbilirubinemia
Abstract
The issue of what is a critical threshold of bilirubin for the neonate in terms of long-term morbidity, however, remains unanswered. The recent large prospective study carried out in the Netherlands by Van de Bor et al. to evaluate the effect of bilirubin on 2-year neurodevelopmental outcome of premature infants with a birthweight less than 1500 gm identified a consistent increase in handicap rate for each 2.9 mg/dl (50 microns mol/L) increase in maximum bilirubin concentration. The percentage of children with both minor and major handicaps increased consistently with increased bilirubin concentration. Logistic regression analysis with the maximum serum bilirubin concentration as the continuous variable and controlling for seven other risk factors identified an odds ratio for handicap of 1.3 with a 95% confidence interval between 1.03 and 1.62, (P less than 0.02). These data suggest that a relationship exists between mild and moderate levels of bilirubin and neurodevelopmental handicap at 2 years of age in premature infants. Van de Bor's study is important because it suggests that we must continue to investigate the risk of low to moderate levels of bilirubin in both premature and full-term infants. The study of neonatal alterations of behavior, BAER conduction time, and cry characteristics in infants with hyperbilirubinemia lends support to the hypothesis that low levels of bilirubin result in neonatal neurobehavioral changes that can be easily measured and recorded by these techniques. BAER changes are mediated by the eighth cranial nerve pathway, and cry characteristics are mediated by the vagal complex cranial nerves. The nuclei of these cranial nerves are located in close proximity to one another in the brainstem, and therefore the insult imposed by bilirubin is reflected not only in changes of these two parameters but by behavioral manifestations (i.e., specifically orientation). Finally, however, evidence exists that reversals of these measured changes do occur after treatment modalities such as exchange transfusion or phototherapy are used. The question of a safe level of bilirubin concentration, and safe duration of exposure relative to long-term minor or soft neurodevelopmental handicaps remains unanswered. Large, controlled, prospective, epidemiologic studies are needed to provide these answers.
Similar articles
-
Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey.Pediatrics. 1989 Jun;83(6):915-20. Pediatrics. 1989. PMID: 2471139 Clinical Trial.
-
Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project.Pediatrics. 1993 Nov;92(5):651-7. Pediatrics. 1993. PMID: 8414851
-
Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age.Pediatrics. 1992 Mar;89(3):359-64. Pediatrics. 1992. PMID: 1371340
-
Hyperbilirubinemia in the term newborn.Am Fam Physician. 2002 Feb 15;65(4):599-606. Am Fam Physician. 2002. PMID: 11871676 Review.
-
Does hyperbilirubinemia damage the brain of healthy full-term infants?Clin Perinatol. 1990 Jun;17(2):331-58. Clin Perinatol. 1990. PMID: 2196133 Review.
Cited by
-
Unbound unconjugated hyperbilirubinemia is associated with central apnea in premature infants.J Pediatr. 2015 Mar;166(3):571-5. doi: 10.1016/j.jpeds.2014.12.003. Epub 2015 Jan 14. J Pediatr. 2015. PMID: 25596965 Free PMC article.
-
Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus.Drugs. 1998 Jul;56(1):23-30. doi: 10.2165/00003495-199856010-00003. Drugs. 1998. PMID: 9664196 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials